Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract.
about
Advanced glycation end products and diabetic complicationsMeasurement of Lens Autofluorescence Can Distinguish Subjects With Diabetes From Those Without.Intensive diabetes therapy and ocular surgery in type 1 diabetes.Simultaneous noninvasive clinical measurement of lens autofluorescence and rayleigh scattering using a fluorescence biomicroscope.Relationship of cytokines and AGE products in diabetic and non-diabetic patients with cataract.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.Pharmacological therapies for cataract and refractive errors: landscaping niches of ocular drug patenting.Cataract surgery and its complications in diabetic patients.Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.Evaluation of antioxidants and argpyrimidine in normal and cataractous lenses in north Indian population.Effect of Oral Alpha Lipoic Acid in Preventing the Genesis of Canine Diabetic Cataract: A Preliminary Study.The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration.Cataract Surgery in Patients with Diabetes: Management Strategies.Preventative effects of Ginkgo biloba extract (EGb761) on high glucose-cultured opacity of rat lens.Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
P2860
Q27687501-FC8B54A8-78DC-402F-BAFF-1E439092143FQ35679083-93C4E18D-895D-474A-AEBA-2CCA2FD10EF5Q35734567-3AB24868-983B-48A5-85B7-869FF4E147DFQ36605760-984E0720-A3B8-43CD-9551-CD9817B097E7Q37376832-1A9562B7-1CC0-4EB0-87E6-8B6C12C0BD71Q38151611-D8E5F09B-86D5-4017-9F8A-EC3F03FF5F6BQ38162916-658E18C4-D7CD-40E4-925A-2A0D6BD01C43Q38261111-A30BABF2-2B5B-44AF-825F-8EC7960B30D1Q39368611-AE3AD9F1-115E-4A16-BE2B-CF21187A768BQ41039997-26A43DE3-FC35-4655-BEB5-7F7E645DB63CQ43378556-89C4F262-D6E8-4E49-BB97-E06E76B285F1Q49299877-A05EB5A0-194E-441D-A4B8-9E6EEFEE6325Q49964021-263C4CB1-4A9C-4E97-8D04-0432940D1155Q53091751-8C8BCBB8-163C-45AB-9423-7B571B7F859CQ58711702-F7472D4A-40A1-4431-B4F3-45AAE06B9509
P2860
Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Advanced glycation end product ...... jects suffering from cataract.
@ast
Advanced glycation end product ...... jects suffering from cataract.
@en
type
label
Advanced glycation end product ...... jects suffering from cataract.
@ast
Advanced glycation end product ...... jects suffering from cataract.
@en
prefLabel
Advanced glycation end product ...... jects suffering from cataract.
@ast
Advanced glycation end product ...... jects suffering from cataract.
@en
P2860
P1433
P1476
Advanced glycation end product ...... jects suffering from cataract.
@en
P2093
Shamshad Zarina
Zehra Hashim
P2860
P304
P356
10.1007/S11357-010-9177-1
P577
2010-09-15T00:00:00Z